About the role
- Location:
- Durham / Research Triangle Park, NC
- Employment type:
- Hybrid / Executive Flexible
The opportunity
BioCryst Pharmaceuticals is entering an important stage of clinical and portfolio expansion, with a commercialized HAE franchise and additional programs advancing through pivotal and early clinical development. The company is currently progressing navenibart through Phase 3 development while advancing BCX17725 in Netherton syndrome. As Executive Vice President, Clinical Development, you will provide enterprise-level leadership across clinical strategy, development planning, medical oversight, regulatory engagement, and execution of global clinical programs. This is designed for a senior clinical development executive who can operate beyond individual programs and help shape how a growing biopharma converts clinical evidence into regulatory milestones, differentiated therapeutic strategies, and long-term portfolio value. You will work closely with executive leadership, regulatory, safety, clinical operations, biostatistics, translational medicine, and commercial functions to establish development priorities and ensure programs move efficiently from clinical evidence toward meaningful patient impact.
Key responsibilities
- Define enterprise clinical-development strategy across late-stage and emerging BioCryst programs
- Provide executive oversight of pivotal, Phase 2, and early-development clinical programs, including development strategy, study design, endpoints, patient populations, and evidence generation
- Lead medical and clinical strategy for programs addressing rare and underserved diseases
- Guide global clinical development plans from first-in-human studies through pivotal development and regulatory submission
- Partner directly with regulatory leadership on FDA and global health-authority strategy, clinical trial design, and development milestones
- Strengthen integration between clinical development, clinical operations, biostatistics, pharmacovigilance, regulatory, CMC, and commercial teams
- Evaluate clinical data and translate emerging findings into portfolio, development, and investment decisions
- Establish rigorous governance for clinical programs, including risk assessment, milestone management, and strategic decision-making
- Represent BioCryst with investigators, key opinion leaders, external scientific experts, and strategic development partners
- Build and mentor a high-performing clinical development organization capable of supporting a broader multi-asset pipeline
- Identify opportunities to accelerate development timelines while maintaining scientific and regulatory rigor
- Advise executive leadership and the Board on clinical-development progress, program risk, competitive positioning, and major development decisions
Candidate profile
- 15+ years of progressive clinical development or pharmaceutical/biopharmaceutical leadership experience
- MD, MD/MBA, or equivalent advanced medical/scientific background
- Proven leadership across Phase I–III clinical development
- Experience designing and executing complex global clinical programs
- Strong understanding of regulatory strategy and interactions with the FDA and other global health authorities
- Demonstrated ability to lead cross-functional clinical development organizations
- Experience translating clinical data into development and portfolio strategy
- Strong understanding of clinical trial methodology, protocol design, patient selection, safety oversight, and medical monitoring
- Executive-level communication skills with the ability to influence scientific, operational, and commercial stakeholders
Preferred qualifications
- Prior CMO, EVP, SVP, or VP-level clinical development leadership
- Experience in rare disease, immunology, hematology, oncology, infectious disease, or other complex therapeutic areas
- Experience taking programs through pivotal development and regulatory decision points
- Background working with CROs, strategic partners, and external clinical-development organizations
- Experience building or scaling clinical organizations within a growth-stage or commercially active biopharma
Compensation & benefits
- Executive-level base compensation with significant annual performance opportunity
- Meaningful long-term equity participation tied to enterprise and pipeline value creation
- Comprehensive medical, dental, and vision coverage
- Executive retirement and financial-planning benefits
- Leadership development and executive coaching resources
- Direct access to senior executive decision-making and portfolio strategy
- Opportunity to influence multiple clinical programs rather than operating within a single therapeutic asset
- High visibility with investigators, regulators, strategic partners, and the broader rare-disease community
